MDMA Stability Sample Clauses

MDMA Stability. Complete details on the chemistry, manufacturing and control of the MDMA to be used are described in Drug Master file (DMF) # 6293. As described in that file, MDMA was prepared for human consumption in 1985 by ▇▇▇▇▇ ▇▇▇▇▇▇▇, Ph.D., at the Dept. of Medicinal Chemistry and Pharmacology, Purdue University. The identity and purity of this MDMA was confirmed using High Performance Liquid Chromatography (HPLC) in 1997 as described in DMF # 6293 and was found to be 99.87% pure. On August 12, 2002, Chemic Laboratories reanalyzed the MDMA at the request of the sponsor prior to starting MAPS’ first U.S. pilot study of MDMA-assisted psychotherapy in people with PTSD. The analysis found the MDMA to be more than 99.7% pure. A more recent analysis performed by ▇▇▇▇▇▇▇ at the request of researcher ▇▇. ▇▇▇▇ ▇▇▇▇ on February, 2006, continued to find a high degree of purity. This analysis found the MDMA in question to be 99.9% pure. This MDMA is currently in use in an ongoing investigation of MDMA-assisted psychotherapy in the U.S., was also used in MP-1 with drug administration ending in 2008, and it was also used in a non-sponsor supported study in 2006[119].